Banque Cantonale Vaudoise’s iShares Biotechnology ETF IBB Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $936K | Sell |
7,397
-580
| -7% | -$73.4K | 0.04% | 364 |
|
2025
Q1 | $1.02M | Buy |
+7,977
| New | +$1.02M | 0.04% | 351 |
|
2024
Q3 | $1.22M | Sell |
8,397
-1,655
| -16% | -$241K | 0.05% | 287 |
|
2024
Q2 | $1.38M | Sell |
10,052
-9,742
| -49% | -$1.34M | 0.05% | 292 |
|
2024
Q1 | $2.72M | Buy |
19,794
+1,443
| +8% | +$198K | 0.11% | 200 |
|
2023
Q4 | $2.49M | Sell |
18,351
-1,454
| -7% | -$197K | 0.11% | 194 |
|
2023
Q3 | $2.42M | Buy |
19,805
+2,101
| +12% | +$257K | 0.12% | 137 |
|
2023
Q2 | $2.25M | Buy |
17,704
+6,631
| +60% | +$842K | 0.1% | 168 |
|
2023
Q1 | $1.43M | Sell |
11,073
-551
| -5% | -$71.1K | 0.07% | 252 |
|
2022
Q4 | $1.53M | Sell |
11,624
-420
| -3% | -$55.2K | 0.08% | 227 |
|
2022
Q3 | $1.41M | Buy |
12,044
+2,611
| +28% | +$305K | 0.08% | 248 |
|
2022
Q2 | $1.11M | Sell |
9,433
-189
| -2% | -$22.2K | 0.06% | 326 |
|
2022
Q1 | $1.26M | Buy |
9,622
+804
| +9% | +$105K | 0.05% | 335 |
|
2021
Q4 | $1.35M | Buy |
8,818
+2,768
| +46% | +$423K | 0.05% | 345 |
|
2021
Q3 | $979K | Buy |
6,050
+614
| +11% | +$99.4K | 0.04% | 410 |
|
2021
Q2 | $890K | Buy |
5,436
+226
| +4% | +$37K | 0.04% | 448 |
|
2021
Q1 | $784K | Sell |
5,210
-330
| -6% | -$49.7K | 0.04% | 430 |
|
2020
Q4 | $840K | Sell |
5,540
-500
| -8% | -$75.8K | 0.05% | 346 |
|
2020
Q3 | $818K | Buy |
6,040
+3,380
| +127% | +$458K | 0.05% | 308 |
|
2020
Q2 | $364K | Sell |
2,660
-180
| -6% | -$24.6K | 0.03% | 489 |
|
2020
Q1 | $306K | Sell |
2,840
-150
| -5% | -$16.2K | 0.03% | 511 |
|
2019
Q4 | $360K | Buy |
+2,990
| New | +$360K | 0.02% | 578 |
|